3101-60-8|4-tert-Butylphenyl glycidyl ether - Shanghai Canbi Pharma Ltd.

Current Location
Home Products
detail

4-tert-Butylphenyl glycidyl ether | CAS:3101-60-8

4-tert-Butylphenyl glycidyl ether

Name：4-tert-Butylphenyl glycidyl ether
CAS：3101-60-8
Synonyms：p-tert-Butylphenyl 1-(2,3-epoxy)propyl ether
Molecular Formula：C₁₃H₁₈O₂
Molecular Weight：206.28
EINESC：221-453-2

Description

Properties

Boiling point	165-170 ºC
Flash point	102 ºC
Density	1.038
Refractive index	1.515

Safety

没有数据	没有数据

SDS

Source	SDS/MSDS Samples
Alfa-Aesar	View & Download
Sigma-Aldrich	View & Download

Synthetic Route

Name	CAS

Articles

Peer-Reviewed Papers

Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases.Tudor I Oprea et al.PloS one, 10(11), e0142182-e0142182 (2015-11-13) Enantiomer?selective pharmacokinetics and metabolism of ketorolac in children.Kauffman RE, et al. Clinical Pharmacology and Therapeutics, 65(4), 382-388 (1999) Drug Repurposing from an Academic Perspective.Tudor I Oprea et al.Drug discovery today. Therapeutic strategies, 8(3-4), 61-69 (2012-03-01) The pharmacokinetics of ketorolac enantiomers following intramuscular administration of the racemate.Hayball PJ, et al. British Journal of Clinical Pharmacology, 37(1), 75-78 (1994) R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.Yuna Guo et al.Molecular cancer therapeutics, 14(10), 2215-2227 (2015-07-25) A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients.Yuna Guo et al.Clinical cancer research : an official journal of the American Association for Cancer Research, 21(22), 5064-5072 (2015-06-14)

Remarks

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Name	CAS

Description

Properties

Safety

SDS

Related Products

Related News